ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

OP

Otsuka Pharmaceutical Development and Commercialization at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Otsuka Pharmaceutical Development and Commercialization brings 2 presentations to ACR Convergence 2026 in Orlando. Its program covers real-world claims and symptom data, including the economic burden of ANCA-associated vasculitis and organ involvement patterns across subgroups of Sjögren's disease.

OrganizationACR Convergence 2026 Attendance
OP
Otsuka Pharmaceutical Development and Commercialization
Pharmaceutical companies
Otsuka subsidiary supporting pharmaceutical development and commercialization.
Poster
Mon Nov 9
10:30am–12:30pm

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Otsuka Pharmaceutical Development and Commercialization

Tell us what you sell and we’ll find the people at Otsuka Pharmaceutical Development and Commercialization most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction